Anti-Glucagon-Cell and Anti-Adrenal-Medullary-Cell Antibodies in Islet-Cell-Autoantibody-Positive Diabetic Children

New England Journal of Medicine

Volumn 310, Issue 23, 1984, Pages 1536-1537

  Schopfer, K ^a   Matter, L ^a   Tenschert, R ^a   Bauer, S ^b   Zuppinger, K ^b   White, Neil H ^c   Skor, Donald A ^c   Cryer, Philip E ^c   Santiago, Julio V ^c  

^a Institute of Clinical Microbiology and Immunology   (Switzerland)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY;

ADRENAL MEDULLA; AUTONOMIC NERVOUS SYSTEM; CHILD; ENDOCRINE SYSTEM; ETIOLOGY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; PANCREAS ISLET ALPHA CELL;

ADOLESCENT; ADRENAL MEDULLA; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCAGON; HUMANS; ISLETS OF LANGERHANS; MALE;

EID: 0021220956     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198406073102320     Document Type: Letter

References (10)

1. Lendrum R, Walker G, Cudworth AG, et al. Islet-cell antibodies in diabetes mellitus. Lancet 1976; 2: 1273–6.
2. Lernmark A, Freedman RR, Hofmann C, et al. Islet-cell surface antibodies in juvenile diabetes mellitus. N Engl J Med 1978; 299: 375–80.
3. Bottazzo GF, Dean BM, Gorsuch AN, Cudworth AG, Doniach D. Complement-fixing islet-cell antibodies in Type I diabetes: possible monitors of active beta-cell damage. Lancet 1980; 1: 668–72.
4. Baekkeskov S, Nielsen JH, Marner B, Bilde T, Ludvigsson J, Lernmark A. Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic cell proteins. Nature 1982; 298: 167–9.
5. Polonsky K, Bergenstal R, Pons G, Schneider M, Jaspan J, Rubenstein A. Relation of counterregulatory responses to hypoglycemia in Type I diabetics. N Engl J Med 1982; 307: 1106–12.
6. White NH, Skor DA, Cryer PE, Levandoski LA, Bier DM. Santiago JV. Identification of Type I diabetic patients at increased risk for hypoglycemia during intensive therapy. N Engl J Med 1983; 308: 485–91.
7. Bolli G, DeFeo P, Compagnucci P, et al. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus: interaction of anti-insulin antibodies and impaired glucagon end ephinephrine secretion. Diabetes 1983; 32: 134–41.
8. White NH, Skor DA, Cryer PE, et al. Identification of Type I diabetic patients at increased risk for hypoglycemia during intensive therapy. N Engl J Med 1983; 308: 485–91.
9. Hoeldtke RD, Boden G, Shuman CR, Owen OE. Reduced epinephrine secretion and hypoglycemia unawareness in diabetic autonomic neuropathy. Ann Intern Med 1982; 96: 459–62.
10. Santiago JV, White NH, Skor DA, Levandoski L, Bier DM, Cryer PE. Defective glucose counterregulation due to deficient glucagon and epinephrine secretory responses limits intensive therapy of insulin dependent diabetes mellitus. Am J Physiol (in press).